Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 17 04:00PM ET
23.58
Dollar change
0.00
Percentage change
0.00
%
CategoryGlobal or ExUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-23.32% Shs Outstand Perf Week-11.75%
SponsorARK Funds ETF Type Tagsequity Return% 3Y-35.96% Total Holdings41 Perf Month-16.44%
Fund Family Bond Type Tagshealthcare Return% 5Y-6.06% AUM1.30B Perf Quarter-18.41%
Index- Average Maturity Tagstechnology Return% 10Y NAV% Perf Half Y-7.38%
Index Weighting Commodity Type Tagsgenomics Return% SI NAV/sh Perf Year-23.32%
Active/Passive Quant Type Tagsmulti-sector Flows% 1M-3.40% 52W Range21.97 - 38.97 Perf YTD-28.13%
Dividend TTM- ESG Type Tags- Flows% 3M-14.42% 52W High-39.49% Beta1.54
Dividend Ex-DateDec 29, 2021 Dividend Type Sector/Theme Flows% YTD-22.65% 52W Low7.33% ATR (14)0.98
Expense0.75% Structure Type Region Flows% 1Y RSI (14)25.02 Volatility3.47% 3.03%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.00 Prev Close23.58
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume2.49M Price23.58
SMA20-13.03% SMA50-18.83% SMA200-20.74% Trades Volume0 Change0.00%
Dec-04-23 07:00AM
Sep-13-23 08:08AM
Dec-19-22 05:22PM
Dec-08-22 02:35PM
Oct-03-22 11:28AM
01:30PM Loading…
Sep-22-22 01:30PM
Jun-09-22 10:55AM
Apr-28-22 11:00AM
Apr-13-22 12:45PM
Feb-08-22 09:38AM
Feb-07-22 06:38PM
01:38PM
09:38AM
Feb-04-22 01:38PM
11:15AM
09:38AM Loading…
Feb-02-22 09:38AM
09:38AM
09:38AM
Feb-01-22 05:38PM
Jan-31-22 05:38PM
01:38PM
Jan-28-22 05:38PM
Jan-27-22 01:38PM
Jan-26-22 01:38PM
01:38PM
Jan-24-22 05:38PM
05:38PM
Jan-21-22 09:38PM
Jan-19-22 09:38PM
05:38PM
09:38PM Loading…
Jan-18-22 09:38PM
05:38PM
01:38PM
09:38AM
Jan-14-22 01:38PM
Jan-13-22 09:38PM
01:38PM
Jan-11-22 09:38AM
Jan-06-22 01:30PM
Dec-28-21 01:38PM
Dec-17-21 03:22PM
Dec-16-21 03:00PM
Dec-08-21 10:45AM
Dec-03-21 11:00AM
Oct-21-21 10:15AM
Oct-15-21 06:00AM
Oct-08-21 06:00AM
Sep-30-21 09:44AM
Sep-24-21 06:00AM
Sep-23-21 06:00AM
06:00AM
Sep-22-21 06:00AM
Sep-17-21 09:34AM
Sep-16-21 06:00AM
Sep-03-21 04:16PM
04:01PM
Sep-02-21 12:00PM
Aug-25-21 08:46AM
Aug-17-21 12:00PM
Aug-12-21 11:06AM
Jul-23-21 06:00AM
Jul-16-21 11:19AM
Jul-13-21 12:09PM
Jun-18-21 08:15PM
Jun-14-21 04:34AM
Jun-07-21 08:00PM
Jun-06-21 07:54AM
May-26-21 08:35AM
May-19-21 11:00AM
May-14-21 02:47PM
Mar-30-21 04:45PM
Mar-25-21 11:00AM
Mar-17-21 08:01AM
Mar-16-21 10:30AM
Mar-08-21 10:00AM
Feb-19-21 09:50AM
Feb-01-21 12:00AM
Jan-29-21 09:45AM
Jan-23-21 11:30PM
Jan-21-21 02:43PM
Jan-08-21 05:36PM
Dec-31-20 06:30AM
Dec-16-20 12:16PM
Nov-09-20 03:15PM
Sep-18-20 12:00AM
Jun-23-20 11:10AM
Apr-06-20 04:30PM
Feb-18-20 11:12AM
Feb-05-20 10:56AM
Jan-23-20 04:29PM
Jan-22-20 09:00AM
08:00AM
Jan-06-20 11:14AM
Dec-23-19 11:18AM
Dec-20-19 09:30AM
Dec-19-19 04:48PM
Dec-12-19 05:33PM
Dec-10-19 04:16PM
Dec-02-19 02:40PM
Nov-29-19 12:15PM
ARK Genomic Revolution ETF seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.